Combined synopsis and solicitation
Sprague-Dawley rats (Charles River)
75F40125Q130321
Food and Drug Administration, FDA Office of Acq Grant SVCS. Fur-Bearing Animal and Rabbit Production.
Awarded
Charles River Laboratories, Inc.
$18,107.65 obligated so far on USAspending
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
Description
As published on SAM.gov.
See attached solicitation/ notice of sole source, requirement for Charles River, 251 Ballardvale St, Wilmington, MA 01887-1096, under the authority of FAR 13.106-1(b)(1) for Sprague Dawley rats for NCTR protocols: E07877.01 and E07876.01.
This acquisition is restricted to Charles River Laboratories as these same rats were provided by Charles River for the methods development for the aforementioned approved protocols and it is imperative the lab continues using this specific strain from Charles River to ensure all behavioral testing and scientific data interpretation can be compared in ongoing research.
A change in strain and supplier would result in invalidation of the studies of which any initial efforts will essentially be uninformative, unpublishable, nor can the results be used to support regulatory activities.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Charles River Laboratories, Inc.
- UEI
- NAPSK1UAMAE5
- CAGE
- 5A148
- Vendor location
- Wilmington, MA
- Contract
- 75F40125F80139 under 47QSWA22D007F, delivery order
- Obligated
- $18,107.65
- Actions
- 1 between August 1, 2025 and August 1, 2025
- Competition
- Full and Open Competition, 1 offer received
- Described as
- Sprague-Dawley Rats
- Match
- solicitation number 75F40125Q130321 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 14, 2025
Combined synopsis and solicitation
Due July 18, 2025 at 3:00 PM EDT. SAM.gov, notice 2961dc37f08e456097d6998af814e371
Points of contact
- Suzanne Martellasuzanne.martella@fda.hhs.gov8705437540